StockNews.com Initiates Coverage on Arcadia Biosciences (NASDAQ:RKDA)

Posted by Scott Moore on Apr 2nd, 2025

StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a note issued to investors on Monday. The firm set a “sell” rating on the basic materials company’s stock.

Arcadia Biosciences Stock Down 2.7 %

Shares of NASDAQ:RKDA opened at $2.89 on Monday. The firm has a fifty day moving average of $4.07 and a two-hundred day moving average of $4.13. Arcadia Biosciences has a 12-month low of $1.85 and a 12-month high of $10.31. The firm has a market capitalization of $3.94 million, a P/E ratio of -0.68 and a beta of 0.86.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Arcadia Biosciences stock. Geode Capital Management LLC acquired a new position in Arcadia Biosciences, Inc. (NASDAQ:RKDA – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned about 0.90% of Arcadia Biosciences as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 17.73% of the company’s stock.

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.